VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
LXEOLexeo Therapeutics, Inc. Common Stock
$5.04$396M
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksLXEOPrice History

LXEO logoLexeo Therapeutics, Inc. Common Stock (LXEO) Stock Price History

Historical prices from 2023 to 2026

$5.04+0.11  (+2.23%)close Jun 22
Returns
1M
+4.7%
3M
-14.3%
YTD
-48.7%
1Y
+16.3%
3Y
-21.1%
5Y
-13.3%
ATH$22.33Jan 2024-77.4%
ATL$1.45Apr 2025pre-split
Avg Vol (50D)712K/ day
52-Week Range$3.60 — $10.99
LowCurrent: $5.04High

Loading 10-year price history...

LXEO Historical Performance

1 YearTotal Return
+16.3%
Price: +16.3%
3 YearsTotal Return
-50.9%
CAGR: -21.1%
Price: -50.9%
5 YearsTotal Return
-50.9%
CAGR: -13.3%
Price: -50.9%
YTD
-48.7%

LXEO Annual Returns

Year-by-year price performance · 2023–2026

Best+48.9%2025
Worst-55.6%2024
Up years2/4
2023+33.5%
2024-55.6%
2025+48.9%
2026-25.3%
2023 annual price return
+33.5%
2024 annual price return
-55.6%
2025 annual price return
+48.9%
2026 annual price return
-25.3%
LessMore
Alpha vs S&P 500
1Y-8.7%
3Y-40.4%
5Y-25.6%

Price returns only.

Download Historical Data

659 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

LXEO Stock Price Trajectory (2023–2026)

As of June 23, 2026, Lexeo Therapeutics, Inc. Common Stock (LXEO) trades at $5.04, representing a +16.3% return over the past year. The stock has delivered a -50.9% total return over five years (-13.3% CAGR), reflecting challenging market conditions.

The stock reached its all-time high of $22.33 on January 18, 2024. From this peak, LXEO has corrected -77.4%, currently trading 29% below its 200-day moving average, suggesting potential weakness.

When compared to Healthcare sector peers RCKT (+18.4% 1Y), KRYS (+163.5% 1Y), and SGMO (-63.3% 1Y), LXEO has underperformed the peer group average. Compare LXEO vs RCKT →

LXEO Historical Price Data · from 2023

Rows 1–50 of 659
Date Open High Low Close Volume Change %
2026-06-225.025.144.865.041.19M+2.23%
2026-06-184.995.344.924.931.08M-1.00%
2026-06-174.845.274.804.981.39M+4.84%
2026-06-164.714.814.514.75696K+2.15%
2026-06-154.535.044.514.65855K+6.41%
2026-06-124.214.644.214.37616K+4.05%
2026-06-114.094.324.034.20575K+1.69%
2026-06-104.184.484.114.13461K-2.59%
2026-06-094.314.404.094.24420K+0.71%
2026-06-084.424.484.164.21489K-3.66%
2026-06-054.704.784.344.37460K-8.58%
2026-06-044.544.864.544.78456K+6.22%
2026-06-034.434.584.414.50619K-0.22%
2026-06-024.714.734.474.51797K-6.24%
2026-06-015.105.114.794.81796K-6.42%
2026-05-295.125.254.955.14480K+1.18%
2026-05-285.085.154.955.08477K-0.20%
2026-05-275.155.245.055.09545K-0.97%
2026-05-265.165.295.075.14455K+0.59%
2026-05-225.235.415.095.11449K-2.29%
2026-05-215.005.294.965.23645K+2.15%
2026-05-204.485.204.485.121.82M+14.29%
2026-05-194.554.664.434.481.01M-4.88%
2026-05-185.115.234.614.71840K-7.47%
2026-05-155.415.475.015.09780K-7.45%
2026-05-145.815.855.475.50417K-4.51%
2026-05-135.696.005.625.761.11M+1.05%
2026-05-126.186.185.675.701.00M-6.86%
2026-05-116.006.435.936.12961K+4.97%
2026-05-085.825.965.675.83972K+0.17%
2026-05-076.176.305.745.82568K-6.58%
2026-05-066.006.295.896.23610K+4.53%
2026-05-055.886.035.745.96325K+2.76%
2026-05-045.745.955.685.80270K+0.52%
2026-05-015.695.865.545.77438K+1.32%
2026-04-305.705.845.655.70301K+0.26%
2026-04-295.755.765.615.68293K-2.24%
2026-04-285.625.895.625.81423K+3.29%
2026-04-275.896.095.605.63720K-3.85%
2026-04-245.995.995.755.85940K-2.66%
2026-04-236.336.365.966.011.07M-5.06%
2026-04-226.356.466.276.331.05M+0.64%
2026-04-216.556.636.226.29736K-3.68%
2026-04-206.896.936.496.53800K-5.50%
2026-04-176.817.016.736.91646K+5.02%
2026-04-166.796.796.476.58474K-3.24%
2026-04-156.656.836.426.80603K+1.95%
2026-04-146.476.906.456.67854K+4.55%
2026-04-135.996.455.936.38900K+6.69%
2026-04-106.436.505.955.98700K-7.00%
…
Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

LXEO — Frequently Asked Questions

Quick answers to the most common questions about buying LXEO stock.

How has LXEO stock performed recently?

LXEO returned +16.3% over the past year, beating its 5-year annualized CAGR of -13.3%. The stock trades below its 200-day moving average, confirming the uptrend.

What is LXEO's all-time high price?

Lexeo Therapeutics, Inc. Common Stock reached $22.33 on 2024-01-18. The 52-week high is $10.99. Current 1-year return of +16.3% places the stock closer to historical peaks.

Where can I download LXEO historical price data?

This page provides LXEO daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2023-2026, downloadable in CSV format.

330 data points · sampled from 659